Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) — The “China Small Molecule CDMO Market Size, Share & Trends Analysis Report by Product (Active Pharmaceutical Ingredients (API), Finished Drug Products), by Drug (Innovators, Generics), by Application (Oncology, Cardiovascular Disease), and Segment Forecasts, 2025-2033” report has been added to ResearchAndMarkets.com’s offering.
The China small molecule CDMO market size was estimated at USD 3.71 billion in 2024 and is projected to reach USD 8.34 billion by 2033, growing at a CAGR of 9.58% from 2025 to 2033
The market is driven by rising drug discovery efforts in fields such as oncology, cardiovascular, and central nervous system, leading many pharmaceutical companies to outsource.
Besides, the small molecule CDMOs in China are characterized by favorable cost structures, a skilled workforce, and a growing range of domestic projects, further becoming appealing partners for both local and international companies. In addition, the market’s expansion is fueled by the rising demand for generics and innovative small molecule therapies, further propelling the trend toward integrated, end-to-end development and manufacturing solutions. In addition, growing technological advancements in the market have played a crucial role in enhancing the capabilities of China’s CDMO sector, which further supports market growth.
Besides, innovations such as process optimization, real-time monitoring via Process Analytical Technology (PAT), and machine learning applications for predictive analytics are increasingly prioritized to improve efficiency and product quality. Moreover, the integration of continuous manufacturing technologies and advanced synthetic chemistry further supports the development of high-potency and complex molecules. This technological advancement has further supported the Chinese CDMOs to compete more effectively in the global arena, particularly for early-phase and high-value niche projects.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Companies Featured
- Lonza
- Catalent, Inc
- Thermo Fisher Scientific Inc.
- Bellen Chemistry
- Siegfried Holding AG
- Recipharm AB
- Eurofins Scientific
- WuXi AppTec
- Asymchem Laboratories
- Langhua Pharmaceutical (Viva Biotech subsidiary)
- Apeloa Pharmaceutical
- JiuZhou Pharmaceutical
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2024 – 2033 |
| Estimated Market Value (USD) in 2024 | $3.71 Billion |
| Forecasted Market Value (USD) by 2033 | $8.34 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | China |
Key Topics Covered:
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Research Methodology
1.4. Information Procurement
1.5. Information Or Data Analysis
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. China Small Molecule CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rise in drug development pipelines
3.2.1.2. Growing reliance on CDMOS for cost-effective and specialized manufacturing services.
3.2.1.3. Capacity expansions by CDMOS
3.2.1.4. Technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Growing demand for biologics
3.2.2.2. Complexity and challenges in the synthesis of certain small molecules, impacting manufacturing efficiency
3.3. Technology Landscape
3.4. Market Analysis Tools
3.4.1. Porter’s Five Force Analysis
3.4.2. PESTEL by SWOT Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. China Small Molecule CDMO Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. China Small Molecule CDMO Market Product Movement Analysis
4.3. China Small Molecule CDMO Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Active Pharmaceutical Ingredients (API)
4.5. Finished Drug Products
Chapter 5. China Small Molecule CDMO Market: Drug Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. China Small Molecule CDMO Market Drug Movement Analysis
5.3. China Small Molecule CDMO Market Size & Trend Analysis, by Drug, 2018 to 2030 (USD Million)
5.4. Innovators
5.5. Generics
Chapter 6. China Small Molecule CDMO Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. China Small Molecule CDMO Market Application Movement Analysis
6.3. China Small Molecule CDMO Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Oncology
6.5. Cardiovascular Disease
6.6. Central Nervous System (CNS) Conditions
6.7. Autoimmune/Inflammation
6.8. Others
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Company Market Share/Assessment Analysis, 2024
7.3. Company Profiles
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Service Benchmarking
7.3.4. Strategic Initiatives
For more information about this report visit https://www.researchandmarkets.com/r/qdtxcm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Chinese Small Molecule CDMO Market
